Zurueck zur Suche

Reporte zur Charge UT7759KA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OR 3 WA 3 CA 3 NV 2 MD 1 CO 1

VAERS 2605503

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

moderat
Staat
OR
Alter
42,0
Geschlecht
F
Eingang
28.03.2023
Impfdatum
11.11.2022
Beginn
11.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Injection site pain Mobility decreased Pain Pain in extremity

Symptomtext

Started with sore arm at site if injection. Continues with pain going down arm to wrist. Also loss of mobility. Cannot lift arm above shoulder without pain. Hurts and aches while at rest, at night in bed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
Tried to do a nerve conduction study but too painful. Dr. check range of motion.
Aktuelle Erkrankungen
Scoliosis,
Vorgeschichte
Asthma, Stroke recovery, hole in heart,
Andere Medikamente
Lipitor, Fioricet, Plavix, Eliquis, Folvite, MAG-OX, methadone, Zofran, Protonix, Phenergan, Vitamin B1, Vitamin B12 shots
Allergien
Clonidine Hci, Famotidine, Penicillin, Zantac, Aspirin, Bee Venom, Butorphanil Tartrate, Citalopram, Codine, Cymbalta, Erythromycin, Escitalopram Oxalate, Ibuprofen, Latex, NSAIDs, Toradil
Vorherige Impfungen
-

VAERS 2621448

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

mild
Staat
MD
Alter
59,0
Geschlecht
F
Eingang
26.04.2023
Impfdatum
25.10.2022
Beginn
22.03.2023
Tage bis Beginn
148,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Bronchitis bacterial Cough Human metapneumovirus test positive Human rhinovirus test Influenza virus test negative Metapneumovirus infection Pyrexia Respiratory syncytial virus test negative SARS-CoV-2 test negative

Symptomtext

I had very deep painful coughing. This lasted a long time and then I broke out in a fever, so I decided to go to the Emergency Room. After sitting in the Emergency Room for a very long time, I was admitted to the hospital for two days. While I was in the hospital, I was given antibiotics through an IV. The doctor diagnosed me with metapneumovirus, and he believed it tuned into a bacterial Bronchitis. I was also prescribed benzonatate, montelukast, guaifenesin, moxifloxacin, and albuterol. I am still dealing with these symptoms at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
2,0
Labordaten
08APR2023 Flu test, negative; 08APR2023 RSV test, negative; 08APR2023 COVID-19 test, negative; 08APR2023 Rhinovirus, negative; 08APR2023 Metapneumovirus, positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
High Cholesterol
Andere Medikamente
Rosuvastatin; multivitamin; vitamin D; coQ10; turmeric; probiotic; calcium; collagen; fish oil; vitamin C
Allergien
Penicillin; arithmomancy; sulfa; surgical glue; seasonal allergies
Vorherige Impfungen
-

VAERS 2568342

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

mild
Staat
WA
Alter
28,0
Geschlecht
F
Eingang
25.01.2023
Impfdatum
23.01.2023
Beginn
24.01.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

swelling redness and warmth at injection site painful to the touch

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Gastro-Esophageal-reflux, Mixed anxiety/depression, Lown-Ganong-Levine Syndrome
Andere Medikamente
Sertraline 100mg benadryl 25 mg
Allergien
Nsaids
Vorherige Impfungen
-

VAERS 2506599

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7759ka

mild
Staat
CA
Alter
34,0
Geschlecht
F
Eingang
12.11.2022
Impfdatum
08.11.2022
Beginn
08.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Injection site bruising Injection site discharge Injection site haemorrhage Injection site pain Injection site swelling Needle issue

Symptomtext

Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: BD Safety glide needles 25 g x 1 inch faulty - caused blood and vaccine to immediately shoot out of patient arm when removing needle after vaccine. Pt states this happened to her once before when doing a blood draw/lab. LOT 2007149 exp 12-31-26 FAULTY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500033

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

mild
Staat
CA
Alter
28,0
Geschlecht
F
Eingang
06.11.2022
Impfdatum
25.10.2022
Beginn
25.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site pain

Symptomtext

Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Additional Details: Received 2 shots on left arm same day. Pt received shots lower than usual and is bruised. Experiences sharp pain on arm on and off.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2685987

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7759ka

gering
Staat
OR
Alter
45,0
Geschlecht
F
Eingang
25.09.2023
Impfdatum
21.09.2023
Beginn
21.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Employee received expired flu vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2685983

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge ut7759ka

gering
Staat
OR
Alter
43,0
Geschlecht
F
Eingang
25.09.2023
Impfdatum
21.09.2023
Beginn
21.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Expired regular dose flu vaccine administered to Employee.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
Received expired flu vaccine. Reported to Employee, Pharmacy, House Supervisor
Allergien
-
Vorherige Impfungen
-

VAERS 2685717

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

gering
Staat
CA
Alter
14,0
Geschlecht
F
Eingang
25.09.2023
Impfdatum
12.09.2023
Beginn
12.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

reported that they have administered an expired FLUZONE QIV-NP vaccine with no reported adverse event; Initial information received on 14-Sep-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 14-year-old female patient and the reporter reported that they have administered an expired influenza quadrival A-B vaccine [Fluzone QIV] vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 12-Sep-2023, the patient received 0.5 ml total dose of suspect influenza quadrival A-B vaccine Suspension for injection (strength: unknown) (lot: UT7759KA, expiry date: 30-Jun-2023) via intramuscular route in the right deltoid for Immunization and reporter reported that they have administered an expired fluzone qiv-np vaccine with no reported adverse event (expired product administered) (latency: same day). Action taken with quadrivalent influenza vaccine (Fluzone QIV) was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2683317

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
18.09.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Expired flu vaccine was given to patient with no reported adverse event; Initial information received on 13-Sep-2023 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves an unknown age and unknown gender patient who was given expired Influenza Quadrival A-B Vaccine [Fluzone quadrivalent] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided. On an unknown date, the patient received an expired dose of suspect Influenza Quadrival A-B Vaccine from 2022/2023 season (lot UT7759KA with unknown strength, dose and expiry date) via intramuscular route in unknown administration site as prophylactic vaccination with no reported adverse event (expired product administered) (latency: same day). It is unknown if there were lab data/results available. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2646360

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

gering
Staat
CO
Alter
57,0
Geschlecht
F
Eingang
16.06.2023
Impfdatum
16.06.2023
Beginn
16.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

PT requested Pfizer Bivalent and Hep A vaccine. RN accidentally administered Pfizer bivalent and flu vaccine. Pt had not received this seasons flu vaccine. RN immediately recognized the mistake and informed pt. PT understands and will f/u for Hep A at a later date due to the pt not wanting more than 2 injections in one day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CKD Asthma
Andere Medikamente
Albuterol Flexeril
Allergien
Versed NSAIDS Shellfish
Vorherige Impfungen
-

VAERS 2579875

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

gering
Staat
WA
Alter
21,0
Geschlecht
F
Eingang
10.02.2023
Impfdatum
03.02.2023
Beginn
03.02.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event Product administration error

Symptomtext

Patient was given a Fluzone on 2/3/2023, but she had already received a flu shot for the 2022-2023 season on 10/7/2022. No adverse reaction or symptoms. Patient was made aware of error immediately after Fluzone was given on 2/3/2023. Provider notified her and provider did not have any recommendations or concerns

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Iron deficiency without anemia
Vorgeschichte
ADHD, chronic insomnia
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2535373

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

gering
Staat
WA
Alter
41,0
Geschlecht
M
Eingang
16.12.2022
Impfdatum
16.12.2022
Beginn
16.12.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product storage error

Symptomtext

The Moderna Bivalent Booster given on 12/16/22 was administered 9:42AM after being punctured at 2pm on 12/15/22 and stored at ambient temperature. This exceeds the 12 hour recommended range to store this vaccine at ambient temperature. The CDC and manufacturer was contacted and information gathered from both. This vaccine is considered safe to administer for up to 24 hours after puncture though there is a minute increase in risk for microbial infection, repeat dosage is not recommended.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
Patient did not have any adverse symptoms or reaction this is an immunization error
Aktuelle Erkrankungen
attention deficit hyperactivity disorder binge eating disorder chronic daily headache compression of brachial plexus Crohn's disease of colon dry eyes essential hypertension exercise-induced asthma generalized anxiety disorder low back strain male hypogonadism neutrophilia obstructive sleep apnea syndrome psoriasis radiculopathy due to lumbar intervertebral disc disorder scalenus anticus syndrome severe recurrent major depression
Vorgeschichte
attention deficit hyperactivity disorder binge eating disorder chronic daily headache compression of brachial plexus Crohn's disease of colon dry eyes essential hypertension exercise-induced asthma generalized anxiety disorder low back strain male hypogonadism neutrophilia obstructive sleep apnea syndrome psoriasis radiculopathy due to lumbar intervertebral disc disorder scalenus anticus syndrome severe recurrent major depression
Andere Medikamente
acetaminophen albuterol sulfate amoxicillin atorvastatin baclofen betamethasone valerate cholecalciferol (vitamin D3) clobetasol dicyclomine docosahexaenoic acid-epa ezetimibe gabapentin ibuprofen lorazepam losartan Lubricating Plus methylp
Allergien
duloxetine lisinopril naproxen
Vorherige Impfungen
-

VAERS 2514977

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7759KA

gering
Staat
NV
Alter
0,2
Geschlecht
F
Eingang
23.11.2022
Impfdatum
17.11.2022
Beginn
17.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

2-month-old patient that was given FLUZONE QUADRIVALENT NP, with no reported adverse event; Initial information received on 17-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 months old female patient who was given influenza quadrival a-b vaccine [Fluzone Quadrivalent], with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis b vaccine; diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (Pentacel); pneumococcal vaccine conj 13v (crm197) (Prevenar 13); and rotavirus vaccine for immunization. On 17-Nov-2022, the patient received a dose of 0.5 ml once of suspect influenza quadrival a-b vaccine Suspension for injection standard (lot UT7759KA, expiry date- 30-JUN-2023) via intramuscular route in the left vastus lateralis for Immunization, with no reported adverse event (product administered to patient of inappropriate age) (latency same day). Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2511950

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge UT7759KA

gering
Staat
NV
Alter
0,2
Geschlecht
F
Eingang
18.11.2022
Impfdatum
17.11.2022
Beginn
17.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Patient in for her 2 month vaccines. Brother and sister were in for the flu vaccine and inadvertently given to the 2 month old. Mom was notified right away called manufacturer for any adverse side effects to watch out for. Mom said patient will be ok. Called today to check on patient. Mom stated doing well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-